APM
PHAS
Avidity Partners Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,361,365
| Closed | -$768K | – | 112 |
|
|
2022
Q3 | $768K | Sell |
4,361,365
-43,635
| -1% | -$7.68K | 0.02% | 93 |
|
|
2022
Q2 | $2.64M | Hold |
4,405,000
| – | – | 0.06% | 69 |
|
|
2022
Q1 | $5.82M | Hold |
4,405,000
| – | – | 0.12% | 66 |
|
|
2021
Q4 | $11.5M | Hold |
4,405,000
| – | – | 0.24% | 61 |
|
|
2021
Q3 | $13.7M | Buy |
4,405,000
+90,000
| +2% | +$280K | 0.3% | 60 |
|
|
2021
Q2 | $16.1M | Buy |
4,315,000
+30,000
| +0.7% | +$112K | 0.43% | 58 |
|
|
2021
Q1 | $14.8M | Buy |
+4,285,000
| New | +$14.8M | 0.41% | 65 |
|